Previous close | 15.60 |
Open | 15.60 |
Bid | 8.80 |
Ask | 15.70 |
Strike | 300.00 |
Expiry date | 2025-04-17 |
Day's range | 15.60 - 15.60 |
Contract range | N/A |
Volume | |
Open interest | 18 |
We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, […]
Over the last 7 days, the market has dropped 3.4%, but over the longer term, it has risen by 20% in the last year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks that can capitalize on these trends is crucial for investors seeking robust returns.
CONSHOHOCKEN, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 10:45 A.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc